Analyst Ratings for Capricor Therapeutics (CAPR)
CAPR Rating Summary
CAPR Price Target Summary
- Highest: $54.00 (Oppenheimer)
- Lowest: $7.00 (Roth/MKM)
- Average: $27.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$27.00 (+355.3%)
* Over Last 12-Mos
Rating Score: 4 / 10
Percentile Rank: 39%
Avg. $ Target:
$27.00 (+355.3%)
* Over Last 12-Mos
Rating Score: 4 / 10
Percentile Rank: 39%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/14/2026 | B.Riley | Madison El-Saadi | Upgrade | Buy (Neutral) |
21.00 (N/A) |
8.30 (5.93) |
-28.55% | Details |
| 9/1/2026 | Piper Sandler | Edward Tenthoff | Upgrade | Overweight (Neutral) |
25.00 (N/A) |
9.59 (5.93) |
-38.16% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
